2009 : Minakem acquires the AstraZeneca's state-of-the-art API site in Dunkirk, which allows to expand by an extra 150m3 reactor capacity, micronization and injectabe capabilities
2005 : Minakem Holding SAS acquired all the assets related to the custom synthesis, including the R&D laboratories, pilot plant and manufacturing resources from SEAC.
Operating under the name of Minakem SAS, headquarters were relocated to Beuvry la Forêt. The company is privately owned.
Minakem establishes Minakem, L.L.C in the United States (New Jersey). This new affiliate manages the groups North-American business and support its development within the domestic market.
1998 : CFPI is acquired by Nufarm Limited, the Australian chemical group, further positioning itself in the agrochemical market. SEAC remains managed as a stand-alone company within the group, focusing on fine chemicals.
1988 : SEAC becomes a 100% subsidiary of the French company CFPI.
1962 : SEAC moves its industrial operations to its current location north of France in Beuvry la Foret near Lille.
1952 : Company’s foundation by Mr. Claude Dufour in the western suburb of Paris (Boulogne under the name of "Laboratoires du Bois de Boulogne" and renamed later on as SEAC.
France
